Molina Healthcare (MOH) Fundamental Analysis: Revenue, Earnings & Valuation

2.04 / 10

Underperform

Fundamental analysis rates MOH as Underperform with a 2.04/10 score. Positive drivers include net cash flow per share growth, while PB‑ROE, revenue‑MV and cash‑MV are negative or neutral. Asset‑MV contributes modestly, but overall earnings growth rates are sharply down.

Analysis Checks(2/10)

Revenue-MV

Value2.47

Score1/3

Weight17.83%

1M Return3.16%

Net cash flow from operating activities per share (YoY growth rate %)

Value-191.22

Score2/3

Weight12.21%

1M Return2.28%

PB-ROE

Value-0.45

Score1/3

Weight-1.92%

1M Return-0.34%

Basic earnings per share (YoY growth rate %)

Value-56.48

Score1/3

Weight3.41%

1M Return0.59%

Total profit (YoY growth rate %)

Value-62.93

Score1/3

Weight7.80%

1M Return1.41%

Net cash flow from operating activities (YoY growth rate %)

Value-183.07

Score1/3

Weight5.25%

1M Return1.00%

Cash-UP

Value-0.15

Score1/3

Weight3.55%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value-56.32

Score1/3

Weight3.71%

1M Return0.65%

Asset-MV

Value-0.55

Score2/3

Weight40.82%

1M Return5.83%

Cash-MV

Value0.02

Score1/3

Weight7.34%

1M Return1.42%

Is MOH undervalued or overvalued?

MOH scores 2.04/10 on fundamentals and holds a Premium valuation at present. Backed by its 11.02% ROE, 1.04% net margin, 14.79 P/E ratio, 1.72 P/B ratio, and -56.48% earnings growth, these metrics solidify its Underperform investment rating.